Qube Research & Technologies LTD Eyenovia, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Eyenovia, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 19,451 shares of EYEN stock, worth $1,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,451
Previous 36,090
46.1%
Holding current value
$1,556
Previous $21,000
52.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EYEN
# of Institutions
54Shares Held
13.4MCall Options Held
13.1KPut Options Held
21.3K-
Armistice Capital, LLC New York, NY8.53MShares$682,7470.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$150,5030.0% of portfolio
-
Geode Capital Management, LLC Boston, MA558KShares$44,6390.0% of portfolio
-
Lasry Marc New York, NY548KShares$43,8240.74% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$31,0490.0% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $2.74M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...